PRESS RELEASE 2015

Ferring announces European launch of CORTIMENT®MMX® (budesonide) for ulcerative colitis, and new data re-confirms safety and efficacy
By pulse in PRESS RELEASE 2015 on 20 February 2015
Ferring Pharmaceuticals announced today the European launch of CORTIMENT®MMX® (budesonide), the first…

pulse
Ferring Pharmaceuticals acquires two phase III ready orthobiologic product candidates from BioSET
By pulse in PRESS RELEASE 2015 on 18 February 2015
Ferring Pharmaceuticals announced today that it has acquired the assets of BioSurface Engineering Technologies, Inc. (BioSET)…

pulse
Ferring Pharmaceuticals moves to strengthen growth with appointment of Chief Medical and Chief Scientific officers
By pulse in PRESS RELEASE 2015 on 27 January 2015
Ferring Pharmaceuticals announced today the appointment of Pascal Danglas, MD as Executive Vice President and Chief Medical Officer…

pulse

This page is not intended for patients or for members of the general public. It is only intended to be used by healthcare professionals.

I confirm that I am a healthcare professional or have a business relationship with Ferring Pharmaceuticals OK

Cette page n'est pas destinée aux patients ou au grand public. Il est uniquement destiné à être utilisé par des professionnels de santé.

Je confirme que je suis un professionnel de la santé ou que j'ai une relation commerciale avec Ferring Pharmaceuticals OK

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals

Ik bevestig dat ik een professionele zorgverlener ben of een zakelijke relatie heb met Ferring Pharmaceuticals OK

Ez az oldal nem betegeknek, vagy nagyközönségnek szól. Az oldalt kizárólag egészségügyi szakemberek használhatják.

Megerősítem, hogy egészségügyi szakember vagyok, vagy üzleti kapcsolatban állok a Ferring Pharmaceuticals céggel OK

Ta strona nie jest przeznaczona dla pacjentów ani dla ogółu odwiedzających. Ta strona stworzona jest dla pracowników sektora ochrony zdrowia.

Potwierdzam, że jestem pracownikiem sektoru ochrony zdrowia lub posiadam relacje biznesowe z Ferring Pharmaceuticals OK

Эта страница не предназначена для пациентов или для широкой публики. Она предназначена только для медицинских работников.

Я подтверждаю, что я медицинский работник или имею деловые отношения с Ferring Pharmaceuticals OK

Ferring announces European launch of CORTIMENT®MMX® (budesonide) for ulcerative colitis, and new data re-confirms safety and efficacy